Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review-Reference-Cited by-同舟云学术

Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review

Published:2020-06-20 Issue:8 Volume:21 Page:781-791
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Asgharzade Samira¹,Talaei Andisheh²,Farkhondeh Tahereh³,Forouzanfar Fatemeh⁴

Affiliation:

1. Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

2. Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran

3. Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

4. Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Stroke is a serious, life-threatening condition demanding vigorous search for new therapies. Recent research has focused on stem cell-based therapies as a viable choice following ischemic stroke, based on studies displaying that stem cells transplanted to the brain not only survive but also cause functional recovery. Growth factors defined as polypeptides that regulate the growth and differentiation of many cell types. Many studies have demonstrated that combined use of growth factors may increase results by the stimulation of endogenous neurogenesis, anti-inflammatory, neuroprotection properties, and enhancement of stem cell survival rates and so may be more effective than a single stem cell therapy. This paper reviews and discusses the most promising new stroke recovery research, including combination treatment.

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Reference117 articles.

1. Mozaffarian D.; Benjamin E.J.; Go A.S.; Arnett D.K.; Blaha M.J.; Cushman M.; Das S.R.; de Ferranti S.; Després J.P.; Fullerton H.J.; Howard V.J.; Huffman M.D.; Isasi C.R.; Jiménez M.C.; Judd S.E.; Kissela B.M.; Lichtman J.H.; Lisabeth L.D.; Liu S.; Mackey R.H.; Magid D.J.; McGuire D.K.; Mohler E.R.; Moy C.S.; Muntner P.; Mussolino M.E.; Nasir K.; Neumar R.W.; Nichol G.; Palaniappan L.; Pandey D.K.; Reeves M.J.; Rodriguez C.J.; Rosamond W.; Sorlie P.D.; Stein J.; Towfighi A.; Turan T.N.; Virani S.S.; Woo D.; Yeh R.W.; Turner M.B.; Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016,133(4),447-454

2. Benjamin E.J.; Virani S.S.; Callaway C.W.; Chamberlain A.M.; Chang A.R.; Cheng S.; Chiuve S.E.; Cushman M.; Delling F.N.; Deo R.; de Ferranti S.D.; Ferguson J.F.; Fornage M.; Gillespie C.; Isasi C.R.; Jiménez M.C.; Jordan L.C.; Judd S.E.; Lackland D.; Lichtman J.H.; Lisabeth L.; Liu S.; Longenecker C.T.; Lutsey P.L.; Mackey J.S.; Matchar D.B.; Matsushita K.; Mussolino M.E.; Nasir K.; O’Flaherty M.; Palaniappan L.P.; Pandey A.; Pandey D.K.; Reeves M.J.; Ritchey M.D.; Rodriguez C.J.; Roth G.A.; Rosamond W.D.; Sampson U.K.A.; Satou G.M.; Shah S.H.; Spartano N.L.; Tirschwell D.L.; Tsao C.W.; Voeks J.H.; Willey J.Z.; Wilkins J.T.; Wu J.H.; Alger H.M.; Wong S.S.; Muntner P.; Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018,137(12),e67-e492

3. Detante O.; Rome C.; Papassin J.; How to use stem cells for repair in stroke patients. Rev Neurol (Paris) 2017,173(9),572-576

4. Rhim T.; Lee M.; Targeted delivery of growth factors in ischemic stroke animal models. Expert Opin Drug Deliv 2016,13(5),709-723

5. Forouzanfar F.; Amin B.; Ghorbani A.; Ghazavi H.; Ghasemi F.; Sadri K.; Mehri S.; Sadeghnia H.R.; Hosseinzadeh H.; New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells. Eur J Pain 2018,22(2),295-310

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors;Cytokine & Growth Factor Reviews;2023-12

2. Therapeutic potentialities of green tea (Camellia sinensis) in ischemic stroke: biochemical and molecular evidence;Metabolic Brain Disease;2023-09-18

3. The potential of hydrogels as a niche for promoting neurogenesis and regulating neuroinflammation in ischemic stroke;Materials & Design;2023-05

4. Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential;Stem Cells International;2022-05-25

5. Historical Perspectives of Regenerative Rehabilitation: Recovering and Restoring Functional Capacity;Physiology in Health and Disease;2022